#USA #New York #Class Action #Gross Law Firm #aTyr Pharma

Class Action Lawsuit Notification for aTyr Pharma, Inc.

Overview of the Lawsuit
The Gross Law Firm is reaching out to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR) regarding a class action lawsuit. Investors who acquired shares during the specified class period should take note of crucial upcoming deadlines and necessary actions.

Key Details

• - Class Period: January 16, 2025, to September 12, 2025
• - Allegations: The lawsuit claims that aTyr made misleading statements to investors regarding the efficacy of its drug, Efzofitimod. During this time, the company presented overly optimistic views while concealing significant negative information regarding the drug’s ability to facilitate reduction in steroid use.
• - The situation escalated on September 15, 2025, when aTyr disclosed that their EFZO-FIT study did not achieve its primary targets during an investor call. Following this revelation, the company's stock plummeted by an astounding 83.2% from $6.03 to $1.02 per share in just one day.

Deadline and Next Steps
It is critical for shareholders to act promptly, as the deadline to register for this class action is set for December 8, 2025. Those acquiring shares of aTyr during the class period can register their information via the Gross Law Firm’s website.

Once registered, you will gain access to a portfolio monitoring system that provides updates about the case's progress. Being a lead plaintiff is optional and does not impact your ability to gain recovery from this lawsuit. There are no costs or obligations involved in joining this class action, thereby ensuring that all impacted parties can participate without fear of financial strain.

Why Choose The Gross Law Firm?
The Gross Law Firm is a reputable class action firm dedicated to protecting the rights of investors. Their commitment lies in holding corporations accountable for deceitful practices and ensuring that investors are not burdened by false or misleading information. With a stellar track record in securities law, the firm aims to provide justice for affected investors when companies fail in their transparency and accountability.

For those who believe they have experienced losses due to aTyr's misleading practices, registering without delay could be a move toward recovery.

Contact Information
For more information or to discuss your rights, reach out to The Gross Law Firm at:

• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Conclusion
If you are an investor of aTyr Pharma, Inc. during the mentioned dates, it is vital to take action before the deadline. The class action lawsuit presents an opportunity to seek reparations for losses incurred due to possible fraudulent activities. Engage now and protect your investment rights.